Business Description
Trulieve Cannabis Corp
NAICS : 325410
SIC : 3741
ISIN : CA89788C1041
Share Class Description:
TRLV: Ordinary Shares (Sub Voting)Total Employee Number:
5,000Compare
Compare
Traded in other countries / regions
TRLV.USATRUL.CanadaT0A.Germany IPO Date
2018-09-26Description
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.56 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | 1.9 | |||||
Interest Coverage | 2.46 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1 | |||||
Beneish M-Score | -3.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.6 | |||||
3-Year EBITDA Growth Rate | 10.4 | |||||
3-Year EPS without NRI Growth Rate | 4.4 | |||||
3-Year Book Growth Rate | -16.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 1.66 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.17 | |||||
9-Day RSI | 51.35 | |||||
14-Day RSI | 49.75 | |||||
3-1 Month Momentum % | -4.08 | |||||
6-1 Month Momentum % | 28.49 | |||||
12-1 Month Momentum % | 64.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.26 | |||||
Quick Ratio | 3.31 | |||||
Cash Ratio | 2.84 | |||||
Days Inventory | 186.87 | |||||
Days Sales Outstanding | 3.5 | |||||
Days Payable | 55.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | 6.54 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.65 | |||||
Operating Margin % | 12.7 | |||||
Net Margin % | -6.93 | |||||
EBITDA Margin % | 28.27 | |||||
FCF Margin % | 16.35 | |||||
OCF Margin % | 21.46 | |||||
ROE % | -6.77 | |||||
ROA % | -2.85 | |||||
ROC (Joel Greenblatt) % | 14.67 | |||||
ROCE % | 5.77 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 65.8 | |||||
Price-to-Owner-Earnings | 15.03 | |||||
PS Ratio | 1.47 | |||||
PB Ratio | 1.5 | |||||
Price-to-Free-Cash-Flow | 7.83 | |||||
Price-to-Operating-Cash-Flow | 6.33 | |||||
EV-to-EBIT | 12.62 | |||||
EV-to-EBITDA | 5.98 | |||||
EV-to-Forward-EBITDA | 6.78 | |||||
EV-to-Revenue | 1.69 | |||||
EV-to-Forward-Revenue | 1.94 | |||||
EV-to-FCF | 8.83 | |||||
Price-to-GF-Value | 1.62 | |||||
Price-to-Projected-FCF | 1.88 | |||||
Earnings Yield (Greenblatt) % | 7.92 | |||||
FCF Yield % | 12.84 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:TRLV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Trulieve Cannabis Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,139.04 | ||
| EPS (TTM) ($) | -2.45 | ||
| Beta | 1.0633 | ||
| 3-Year Sharpe Ratio | 0.62 | ||
| 3-Year Sortino Ratio | 1.46 | ||
| Volatility % | 147.38 | ||
| 14-Day RSI | 49.75 | ||
| 14-Day ATR ($) | 0.59847 | ||
| 20-Day SMA ($) | 8.6425 | ||
| 12-1 Month Momentum % | 64.46 | ||
| 52-Week Range ($) | 4.616 - 13.28 | ||
| Shares Outstanding (Mil) | 192.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Trulieve Cannabis Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Trulieve Cannabis Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2025 | 2025-11-05 08:30 | 6.62 (-3.78%) | ||
| Third quarter earnings results for 2025 | 2025-11-05 | 6.62 (-3.78%) | ||
| Second quarter earnings conference call for 2025 | 2025-08-06 08:30 | 5.55 (+11.45%) | ||
| Second quarter earnings results for 2025 | 2025-08-06 | 5.55 (+11.45%) | ||
| General meeting for 2025 | 2025-06-12 10:00 | 3.77 (+2.45%) | ||
| First quarter earnings conference call for 2025 | 2025-05-09 08:30 | 4.46 (+2.29%) | ||
| First quarter earnings results for 2025 | 2025-05-09 | 4.46 (+2.29%) | ||
| Fourth quarter earnings conference call for 2024 | 2025-02-28 08:30 | 4.36 (+5.01%) | ||
| Annual report for 2024 | 2025-02-28 | 4.36 (+5.01%) | ||
| Fourth quarter earnings results for 2024 | 2025-02-28 | 4.36 (+5.01%) |
Show
Entries
Trulieve Cannabis Corp Frequently Asked Questions
What is Trulieve Cannabis Corp(TRLV)'s stock price today?
The current price of TRLV is $9.08. The 52 week high of TRLV is $13.28 and 52 week low is $4.62.
When is next earnings date of Trulieve Cannabis Corp(TRLV)?
The next earnings date of Trulieve Cannabis Corp(TRLV) is 2026-11-05 Est..
Does Trulieve Cannabis Corp(TRLV) pay dividends? If so, how much?
Trulieve Cannabis Corp(TRLV) does not pay dividend.
Guru Commentaries on NYSE:TRLV
No articles.
Press Release
Articles on Trulieve Cannabis Corp
Headlines
See More- 1
Aug 07, 2026
Trulieve anticipates at least $225M in 2026 operating cash flow while raising capex outlook to $95M
Seeking Alpha • 3:46pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers